The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Abstract
OBJECTIVE: Methamphetamine is a popular and highly addictive drug of abuse that has raised concerns because it has been shown in laboratory animals to be neurotoxic to dopamine terminals. The authors evaluated if similar changes occur in humans and assessed if they were functionally significant. METHOD: Positron emission tomography scans following administration of [(11)C]d-threo-methylphenidate (a dopamine transporter ligand) measured dopamine transporter levels (a marker of dopamine cell terminals) in the brains of 15 detoxified methamphetamine abusers and 18 comparison subjects. Neuropsychological tests were also performed to assess motor and cognitive function. RESULTS: Methamphetamine abusers showed significant dopamine transporter reduction in the striatum (mean differences of 27.8% in the caudate and 21.1% in the putamen) relative to the comparison subjects; this reduction was evident even in abusers who had been detoxified for at least 11 months. Dopamine transporter reduction was associated with motor slowing and memory impairment. CONCLUSIONS: These results provide evidence that methamphetamine at dose levels taken by human abusers of the drug leads to dopamine transporter reduction that is associated with motor and cognitive impairment. These results emphasize the urgency of alerting clinicians and the public of the long-term changes that methamphetamine can induce in the human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationStriatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Vingerhoets, F. J. G., Schulzer, M., Calne, D. B., & Snow, B. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410111 · Cited by 359
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R. M., Zea-Ponce, Y., Zoghbi, S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359
Frost, J. J., Rosier, A. J., Reich, S. G., Smith, J. S., Ehlers, M. D., Snyder, S. H., Ravert, H. T., & Dannals, R. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340331 · Cited by 320
Maggio, R., Riva, M., Vaglini, F., Fornai, F., Molteni, R., Armogida, M., Racagni, G., & Corsini, G. U. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062439.x · Cited by 218
Villemagne, V., Yuan, J., Wong, D. F., Dannals, R. F., Hatzidimitriou, G., Mathews, W. B., Ravert, H. T., Musachio, J., McCann, U. D., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00419.1998 · Cited by 211
Cited by
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Self-citationThe mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
“, ‘‘avolition’’), stimulant withdrawal (Volkow et al., 2001), Parkinsonism (Friedman et al.”
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
Self-citationEffort-related functions of nucleus accumbens dopamine and associated forebrain circuits
Salamone, J. D., Correa, M., Farrar, A., & Mingote, S. M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0668-9 · Cited by 1,000
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Self-citationThe addicted human brain: insights from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18533 · Cited by 916
Self-citationA review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Self-citationNew Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
Wittmann, B. C., Schott, B. H., Guderian, S., Frey, J. U., Heinze, H.-J., & Düzel, E. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.010 · Cited by 698
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Volkow, N. D., Wang, G., Fowler, J. S., Tomasi, D., Telang, F., & Baler, R. (2010) · BioEssays · doi:10.1002/bies.201000042 · Cited by 532
Self-citationDavidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 521
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 498
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons
RIPPETH, J. D., HEATON, R. K., CAREY, C. L., MARCOTTE, T. D., MOORE, D. J., GONZALEZ, R., WOLFSON, T., GRANT, I., & GROUP, T. H. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704101021 · Cited by 435
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 434
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 430
Self-citationDeficits in response inhibition associated with chronic methamphetamine abuse
Monterosso, J. R., Aron, A. R., Cordova, X., Xu, J., & London, E. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.002 · Cited by 425
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00008 · Cited by 398
Self-citationImplications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 393
London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 384
Methamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Burstein, M. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1503 · Cited by 365
The Methamphetamine Problem in the United States
Gonzales, R., Mooney, L., & Rawson, R. A. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103600 · Cited by 361
Salamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350
Goldstein, R. Z., Leskovjan, A. C., Hoff, A. L., Hitzemann, R., Bashan, F., Khalsa, S. S., Wang, G.-J., Fowler, J. S., & Volkow, N. D. (2004) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.04.002 · Cited by 348
Self-citationInverse Association Between BMI and Prefrontal Metabolic Activity in Healthy Adults
Volkow, N. D., Wang, G., Telang, F., Fowler, J. S., Goldstein, R. Z., Alia‐Klein, N., Logan, J., Wong, C., Thanos, P. K., Ma, Y., et al. (2009) · Obesity · doi:10.1038/oby.2008.469 · Cited by 344
“, Parkinson’s Disease, methamphetamine abuse) in whom impairments in executive function have been shown to be associated with markers of DA damage (25,26).”
Self-citationAshok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330
Self-citationThomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 315
Drug Use and Medication Adherence among HIV-1 Infected Individuals
Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., Myers, H. F., & Longshore, D. (2007) · AIDS and Behavior · doi:10.1007/s10461-006-9152-0 · Cited by 305
Imaging the Addicted Human Brain
Fowler, J., Volkow, N., Kassed, C., & Chang, L. (2007) · Science & Practice Perspectives · doi:10.1151/spp07324 · Cited by 302
Self-citationKalechstein, A. D., Newton, T. F., & Green, M. M. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.2.215 · Cited by 288
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.90 · Cited by 287
Cadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286
Neuropsychological function and delay discounting in methamphetamine-dependent individuals
Hoffman, W. F., Moore, M., Templin, R., McFarland, B., Hitzemann, R. J., & Mitchell, S. H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0494-0 · Cited by 286
Self-citationAmphetamine toxicities: Classical and emerging mechanisms
Yamamoto, B. K., Moszczynska, A., & Gudelsky, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05141.x · Cited by 279
Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms
Cadet, J. L., Krasnova, I. N., Jayanthi, S., & Lyles, J. (2007) · Neurotoxicity Research · doi:10.1007/bf03033567 · Cited by 272
Effects of Methamphetamine Dependence and HIV Infection on Cerebral Morphology
Jernigan, T. L., Gamst, A. C., Archibald, S. L., Fennema-Notestine, C., Mindt, M. R., Marcotte, T. L., Heaton, R. K., Ellis, R. J., & Grant, I. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1461 · Cited by 268
Potential adverse effects of amphetamine treatment on brain and behavior: a review
Berman, S. M., Kuczenski, R., McCracken, J. T., & London, E. D. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 261
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers
Johanson, C.-E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., Galloway, G. P., Koeppe, R. A., Kilbourn, M. R., Robbins, T., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0330-6 · Cited by 233
“In the study by Volkow et al. (2001b) that demonstrated decrease in levels of DAT binding after 2 weeks to 36 months of abstinence, the MA users were also evaluated with a battery of cognitive tests.”
BackgroundMethodResultInfluentialA double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159
Dopamine, effort-based choice, and behavioral economics: basic and translational research.
Salamone, J. D., Correa, M., Yang, J.-H., Rotolo, R., & Presby, R. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00052 · Cited by 142
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers
London, E. D., Berman, S. M., Voytek, B., Simon, S. L., Mandelkern, M. A., Monterosso, J., Thompson, P. M., Brody, A. L., Geaga, J. A., Hong, M. S., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.039 · Cited by 136
Neuroimaging of children following prenatal drug exposure
Derauf, C., Kekatpure, M., Neyzi, N., Lester, B., & Kosofsky, B. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.03.001 · Cited by 122
Longo, M., Wickes, W., Smout, M., Harrison, S., Cahill, S., & White, J. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02717.x · Cited by 122
Rose, M. E., & Grant, J. E. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230802177656 · Cited by 121
Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation
Kim, B., Yun, J., & Park, B. (2020) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.044 · Cited by 116
Boileau, I., Rusjan, P., Houle, S., Wilkins, D., Tong, J., Selby, P., Guttman, M., Saint-Cyr, J. A., Wilson, A. A., & Kish, S. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3008-08.2008 · Cited by 100
Chou, Y.-H., Huang, W.-S., Su, T.-P., Lu, R.-B., Wan, F.-J., & Fu, Y.-K. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.05.002 · Cited by 78
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal
CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801935672 · Cited by 74
Motaghinejad, M., Motevalian, M., & Shabab, B. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.015 · Cited by 72
Kalechstein, A. D., De La Garza, II, & Newton, T. F. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00052.x · Cited by 67
mTOR Modulates Methamphetamine‐Induced Toxicity through Cell Clearing Systems
Lazzeri, G., Biagioni, F., Fulceri, F., Busceti, C. L., Scavuzzo, M. C., Ippolito, C., Salvetti, A., Lenzi, P., & Fornai, F. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6124745 · Cited by 53
Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study
Hellem, T. L., Sung, Y.-H., Shi, X.-F., Pett, M. A., Latendresse, G., Morgan, J., Huber, R. S., Kuykendall, D., Lundberg, K. J., & Renshaw, P. F. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1100471 · Cited by 49
Artenie, A. A., Bruneau, J., Zang, G., Lespérance, F., Renaud, J., Tremblay, J., & Jutras-Aswad, D. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.011 · Cited by 46
Eugenin, E. A., Greco, J. M., Frases, S., Nosanchuk, J. D., & Martinez, L. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit117 · Cited by 45
Hester, R., Lee, N., Pennay, A., Nielsen, S., & Ferris, J. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021791 · Cited by 42
An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence
Meredith, C. W., Jaffe, C., Yanasak, E., Cherrier, M., & Saxon, A. J. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10399875 · Cited by 37
Pérez-Mañá, C., Castells, X., Vidal, X., Casas, M., & Capellà, D. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.08.012 · Cited by 33
Johnson, B. A., Roache, J. D., Ait-Daoud, N., Wallace, C., Wells, L. T., & Wang, Y. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1998-0 · Cited by 33
Lisa, P., Felicia, K., Laura, H., Daniela, K., Marlies, R., Stefanie, N., Maik, S. J., Anne, S., Maximilian, S., Kirsi, M., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112505 · Cited by 23
Economic Analysis of Methamphetamine Prevention Effects and Employer Costs
Guyll, M., Spoth, R., & Crowley, D. M. (2011) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2011.72.577 · Cited by 20
Metadata
- Authors
- Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., Logan, J., Wong, C., & Miller, E. N.
- Venue
- American Journal of Psychiatry
- Published
- 2001-03-01
- Volume
- 158
- Issue
- 3
- Pages
- 377-382
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2163320407
- Cited by
- 984
- References
- 27
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.